Impaired Hepatic Function

Recruiting

Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function

NCT07682818

Conditions

Impaired Hepatic Function

Locations

• Centrum Badan Klinicznych Piotr Napora Lekarze sp.p. — Wroclaw, Poland
• Summit Clinical Research s.r.o. — Bratislava, Bratislava Region, Slovakia
• Summit Clinical Research s.r.o. — Malacky, Slovakia

View Trial Details

Completed

Evaluating Patients With Impaired Hepatic Function

NCT00398424

Conditions

Impaired Hepatic Function

Locations

• Premiere Oncology of Arizona — Scottsdale, Arizona, United States
• Yale Cancer Center — New Haven, Connecticut, United States
• University of Kentucky/Division of Hematology/Oncology and Blood Marrow Transplantation — Lexington, Kentucky, United States
• University of Maryland/Greenebaum Cancer Center — Baltimore, Maryland, United States

View more locations Show fewer locations Loading locations...

View Trial Details

Completed

Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function

NCT04823702

Conditions

Impaired Hepatic Function

Locations

• NGM Clinical Study Site 110 — Miami, Florida, United States
• NGM Clinical Study Site 111 — Orlando, Florida, United States
• NGM Clinical Study Site 113 — San Antonio, Texas, United States

View Trial Details

Completed

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects

NCT02135302

Conditions

Impaired Hepatic Function

Locations

• Davita Clinical Research — Lakewood, Colorado, United States
• Orlando Clinical Research Center — Orlando, Florida, United States
• New Orleans Center for Clinical Research — Knoxville, Tennessee, United States

View Trial Details

Completed

Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011

NCT02388620

Conditions

Impaired Hepatic Function, Normal Hepatic Function

Locations

• Anaheim Clinical Trials — Anaheim, California, United States
• University of Miami — Coral Gables, Florida, United States
• Orlando Clinical Research Center — Orlando, Florida, United States

View Trial Details

Completed

Effect of Hepatic Impairment on LDK378 Pharmacokinetics

NCT01950481

Conditions

Impaired Hepatic Function, Normal Hepatic Function

Locations

• DaVita Clinical Research-Denver — Lakewood, Colorado, United States
• Avail. Clinical Research, LLC — DeLand, Florida, United States
• Clinical Research of Miami, INC CLDK378A2110 — Miami, Florida, United States
• Orlando Clinical Research Center — Orlando, Florida, United States

View more locations Show fewer locations Loading locations...

View Trial Details

Completed

Effect of Hepatic Impairment on LDE225..

NCT01764776

Conditions

Impaired Hepatic Function, Normal Hepatic Function

Locations

• University of Miami Div. of Clinical Pharmacology — Miami, Florida, United States
• Novartis Investigative Site — Brussels, Belgium
• Novartis Investigative Site — Sofia, Bulgaria
• Novartis Investigative Site — Berlin, Germany

View more locations Show fewer locations Loading locations...

View Trial Details